• Thor Medical completed its first customer delivery of high-purity Thorium-228 from its AlphaOne facility at Herøya Industrial Park.
• The shipment follows last week’s production start, marking the start of commercial supply from AlphaOne.
• Customer deliveries are expected to continue as output ramps toward 21,000 patient dose equivalents within three years.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Thor Medical ASA published the original content used to generate this news brief on August 05, 2026, and is solely responsible for the information contained therein.